These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32885898)

  • 1. Professional Medical Writer Assistance in Oncology Clinical Trials.
    Kouzy R; Abi Jaoude J; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Verma V; Fuller CD; Minsky BD; Rödel C; Taniguchi CM; Ludmir EB
    Oncologist; 2020 Nov; 25(11):e1812-e1815. PubMed ID: 32885898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and Characteristics of Trials Using Medical Writer Support in High-Impact Oncology Journals.
    Buck E; Haslam A; Tuia J; Prasad V
    JAMA Netw Open; 2023 Feb; 6(2):e2254405. PubMed ID: 36723940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review.
    Evuarherhe O; Gattrell W; White R; Winchester CC
    Res Integr Peer Rev; 2019; 4():14. PubMed ID: 31338209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration approvals in phase 3 Cancer clinical trials.
    Abi Jaoude J; Kouzy R; Ghabach M; Patel R; Pasalic D; Ghossain E; Miller AB; Lin TA; Verma V; Fuller CD; Subbiah V; Minsky BD; Ludmir EB; Taniguchi CM
    BMC Cancer; 2021 Jun; 21(1):695. PubMed ID: 34118915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who writes dermatology randomized controlled trials? The need to specify the role of medical writers.
    Steele L; Lee HL; Earp E; Hong A; Thomson J
    Clin Exp Dermatol; 2021 Aug; 46(6):1086-1088. PubMed ID: 33914938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
    Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
    JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and attitudes of Indian surgeons regarding professional medical writing support.
    Das N; Das S
    Perspect Clin Res; 2018; 9(3):127-132. PubMed ID: 30090711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of the Randomized Clinical Trial in the Era of Precision Oncology.
    Del Paggio JC; Berry JS; Hopman WM; Eisenhauer EA; Prasad V; Gyawali B; Booth CM
    JAMA Oncol; 2021 May; 7(5):728-734. PubMed ID: 33764385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation.
    Fundytus A; Wells JC; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):28-35. PubMed ID: 34479769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study.
    Gattrell WT; Hopewell S; Young K; Farrow P; White R; Wager E; Winchester CC
    BMJ Open; 2016 Feb; 6(2):e010329. PubMed ID: 26899254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
    Rizzo A; Mollica V; Massari F
    JAMA Oncol; 2021 Oct; 7(10):1577. PubMed ID: 34436578
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
    Stewart DJ; Wheatley-Price P
    JAMA Oncol; 2021 Oct; 7(10):1577-1578. PubMed ID: 34436567
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
    Schindler TM; Marchington JM; Flores GV
    JAMA Oncol; 2021 Oct; 7(10):1578-1579. PubMed ID: 34436547
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity-Reply.
    Del Paggio JC; Eisenhauer EA; Booth CM
    JAMA Oncol; 2021 Oct; 7(10):1579-1580. PubMed ID: 34436516
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
    Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
    JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.
    Ludmir EB; Jethanandani A; Mainwaring W; Miller AB; Lin TA; Espinoza AF; Verma V; VanderWalde NA; Grossberg AJ; Guadagnolo BA; Koong AC; Jagsi R; Thomas CR; Fuller CD
    J Natl Cancer Inst; 2019 Dec; 111(12):1358-1360. PubMed ID: 31165160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Definitions and Statistical Tests in Oncology Studies: A Systematic Review of the Reporting Consistency.
    Rivoirard R; Duplay V; Oriol M; Tinquaut F; Chauvin F; Magne N; Bourmaud A
    PLoS One; 2016; 11(10):e0164275. PubMed ID: 27716793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Audit of Interim Analyses of Randomized Controlled Trials (RCTs) Published in Three High Impact Factor Medical Journals Over a Seven- year Period (2012-2018).
    Bose D; Ravi R; Gogtay N; Thatte UM; Borse T
    Rev Recent Clin Trials; 2021; 16(4):403-408. PubMed ID: 34259150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
    Jairam V; Yu JB; Aneja S; Wilson LD; Lloyd S
    Am J Clin Oncol; 2017 Jun; 40(3):312-317. PubMed ID: 25374144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.
    Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD
    Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.